Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
Drug-resistant TB

Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval

Press Release 23 Mar 2017
 
Drug-resistant TB

Open letter regarding registration and availability of delamanid in South Africa

Speech 22 Mar 2017
 
Drug-resistant TB

"Now I am better" - A grueling fight against TB

Patient and Staff Stories 17 Mar 2017
 
Videos and Photos

A Grueling Fight against TB

17 Mar 2017
Videos and Photos
 
Drug-resistant TB

Georgia: endTB partnership launches clinical trial to target toughest strains of tuberculosis

Press Release 7 Mar 2017
 
Drug-resistant TB

Now I am better: A gruelling fight against TB

24 Feb 2017